Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
Ladhani SN, Dowell AC, Jones S, Hicks B, Rowe C, Begum J, Wailblinger D, Wright J, Owens S, Pickering A, Shilltoe B, McMaster P, Whittaker E, Zuo J, Powell A, Amirthalingam G, Mandal S, Lopez-Bernal J, Ramsay ME, Kissane N, Bell M, Watson H, Ho D, Hallis B, Otter A, Moss P, Cohen J. Ladhani SN, et al. Among authors: ho d. Lancet Infect Dis. 2023 Sep;23(9):1042-1050. doi: 10.1016/S1473-3099(23)00270-0. Epub 2023 Jun 16. Lancet Infect Dis. 2023. PMID: 37336224 Free article.
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation.
Wang Q, Li Z, Ho J, Guo Y, Yeh AY, Mohri H, Liu M, Wang M, Yu J, Shah JG, Chang JY, Herbas F, Yin MT, Sobieszczyk ME, Sheng Z, Liu L, Ho DD. Wang Q, et al. Among authors: ho j, ho dd. Lancet Infect Dis. 2022 Dec;22(12):1666-1668. doi: 10.1016/S1473-3099(22)00694-6. Epub 2022 Oct 31. Lancet Infect Dis. 2022. PMID: 36328002 Free PMC article. No abstract available.
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster.
Wang Q, Bowen A, Tam AR, Valdez R, Stoneman E, Mellis IA, Gordon A, Liu L, Ho DD. Wang Q, et al. Among authors: ho dd. Lancet Infect Dis. 2023 May;23(5):527-528. doi: 10.1016/S1473-3099(23)00181-0. Epub 2023 Mar 29. Lancet Infect Dis. 2023. PMID: 37003292 Free PMC article. No abstract available.
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6.
Wang Q, Guo Y, Zhang RM, Ho J, Mohri H, Valdez R, Manthei DM, Gordon A, Liu L, Ho DD. Wang Q, et al. Among authors: ho j, ho dd. Lancet Infect Dis. 2023 Oct;23(10):e397-e398. doi: 10.1016/S1473-3099(23)00555-8. Epub 2023 Sep 11. Lancet Infect Dis. 2023. PMID: 37708906 No abstract available.
Sorted-cell sequencing on HCC specimens reveals EPS8L3 as a key player in CD24/CD13/EpCAM-triple positive, stemness-related HCC cells.
Tsui YM, Ho DW, Sze KM, Lee JM, Lee E, Zhang Q, Cheung GC, Tang CN, Tang VW, Cheung ET, Lo IL, Chan AC, Cheung TT, Ng IO. Tsui YM, et al. Among authors: ho dw. Cell Mol Gastroenterol Hepatol. 2024 May 13:S2352-345X(24)00112-7. doi: 10.1016/j.jcmgh.2024.05.006. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38750898
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants.
Piepenbrink MS, Khalil AM, Chang A, Mostafa A, Basu M, Sarkar S, Panjwani S, Ha YH, Ma Y, Ye C, Wang Q, Green TJ, Kizziah JL, Erdmann NB, Goepfert PA, Liu L, Ho DD, Martinez-Sobrido L, Walter MR, Kobie JJ. Piepenbrink MS, et al. Among authors: ho dd. bioRxiv [Preprint]. 2024 Apr 29:2024.04.27.591446. doi: 10.1101/2024.04.27.591446. bioRxiv. 2024. PMID: 38746414 Free PMC article. Preprint.
2,286 results